Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and central nervous system agents. Its structure enables selective binding in biological targets, making it valuable in drug discovery for oncology and neurological disorders. The fluorophenyl ether moiety enhances metabolic stability and bioavailability in final drug forms. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its rigid azetidine ring and fluorinated aromatic group.